Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Cushing's Syndrome

3,4-dihydroxyphenylacetic acid has been researched along with Cushing's Syndrome in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Millington, WR1
Dybdal, NO1
Dawson, R1
Manzini, C1
Mueller, GP1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Cushing's Syndrome

ArticleYear
Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary.
    Endocrinology, 1988, Volume: 123, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Endorphin; Cushing Syndrome; Dopamine; Female; Horse D

1988